IRVING, Texas—PFO Global, Inc. (OTCQB: PFGB) has entered into an agreement with GB Pharma Holdings, to bring cost effective, high quality prescription lenses and finished eyewear to Africa and various distribution channels in the U.S.

“We are excited to work with PFO Global to bring quality prescription eyewear to Africa,” stated Dr. Gloria Herndon, CEO of GB Pharma Holdings, a Washington, D.C.-based global pharmaceutical company. “We work with international agencies and regulatory bodies to bring cost effective, quality medical products to Africa. PFO Global’s prescription lenses are an incredible addition to our product line.”

Rudolf Suter, president and CEO of PFO Global said, "We’re honored to join forces with GB Pharma Holdings and Dr. Herndon in an effort to advance vision solutions available to Africa. According to the World Health Organization, the region has nearly 153 million people with visual impairment due to uncorrected refractive errors. Approximately 80 percent of the causes of visual impairment including blindness are believed to be avoidable.

“We believe our partnership with GB Pharma presents PFO Global with the unique opportunity to not only expand our business and address a sizeable untapped market, but to also play a positive role in the fight against blindness by providing eyecare services to a region currently grossly underserved,” Suter commented.